UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis

Craven, Brian; Lester, William; Boyce, Sara; Thomas, Will; Kanny, Angela; Davies, Claire; Pavord, Sue; ... Scully, Marie; + view all (2022) Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis. Blood , 139 (16) pp. 2553-2560. 10.1182/blood.2021014684. Green open access

[thumbnail of Natural history of PF4 antibodies.pdf]
Preview
Text
Natural history of PF4 antibodies.pdf - Published Version

Download (1MB) | Preview

Abstract

The COVID-19 pandemic has resulted in the rapid development of a range of vaccines against SARS-CoV-2. Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a rare but life-threatening complication of primarily adenoviral-based vaccines associated with the presence of antibodies to a PF4/polyanion neoepitope and measured by using enzyme-linked immunosorbent assays. Presented are serial anti–PF4/polyanion antibody, platelet, and D-dimer measurements in a large cohort of patients and their relation to relapse. Overall, 51% of patients using the Stago assay had persistently positive anti–PF4/polyanion levels 100 days' postdiagnosis, whereas 94% of patients monitored by using the Immucor assay remain positive. The median duration of positivity of the PF4 assay is 87 days, with 72% of patients remaining positive after a median follow-up of 105 days. The use of plasma exchange seemed to reduce anti–PF4/polyanion levels and increase platelet counts in the acute setting more rapidly than other therapies. The rate of relapse in this study was 12.6%, with all relapsed cases exhibiting persistently positive PF4 antibodies and falling platelet counts. Only one patient had extension of their thrombosis. Overall, despite the persistence of PF4 antibodies in 72% of patients, the rate of relapse was low and did not seem to result in recrudescence of the aggressive clinical picture seen at index presentation. Monitoring of these patients in the UK cohort is ongoing and will aid in definition of the natural history of this novel condition.

Type: Article
Title: Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1182/blood.2021014684
Publisher version: https://doi.org/10.1182/blood.2021014684
Language: English
Additional information: This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Clinical Trials and Observations, Free Research Articles, Platelets and Thrombopoiesis, Thrombosis and Hemostasis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
URI: https://discovery.ucl.ac.uk/id/eprint/10154833
Downloads since deposit
111Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item